As of 2024-07-27, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (42.88) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -325.7%.
The range of the Relative Valuation is (36.13) - (43.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 31.6x | 30.8x |
| Forward P/E multiples | 24.5x - 29.6x | 27.4x |
| Fair Price | (36.13) - (43.56) | (42.88) |
| Upside | -290.2% - -329.3% | -325.7% |
| Date | P/E |